MacroGenics Announces Date of First Quarter 2023 Financial Results Conference Call

May 4, 2023

https://www.globenewswire.com/news-release/2023/05/04/2662130/0/en/MacroGenics-Announces-Date-of-First-Quarter-2023-Financial-Results-Conference-Call.html

ROCKVILLE, MD, May 04, 2023 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq:MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company will release its financial results for the first quarter of 2023 after the market closes on Tuesday, May 9, 2023. MacroGenics will host a conference call to discuss the financial results and recent corporate progress on Tuesday, May 9, 2023, at 4:30 pm ET.

Read more at globenewswire.com

Related news for (MGNX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.